CTN Dissemination Library: Delaware Valley Node

DELAWARE VALLEY NODE

DELAWARE VALLEY NODE (no longer active)

George E. Woody, MD [email]
Principal Investigator
Professor
Department of Psychiatry
University of Pennsylvania
Treatment Research Institute
600 Public Ledger Bldg.
150 S. Independence Mall - West
Philadelphia, PA 19106-3475

	Find Node Publications

	Node Facebook page

	Node web site NIDA web site

The Delaware Valley Node joined the Clinical Trials Network in September 1999 and includes Delaware, Eastern Pennsylvania, and New Jersey. The DV Node member organizations provide services to patients with every type of substance use disorder including special populations such as: 1) persons living with HIV, 2) adolescents, 3) veterans, 4) women with children, and 5) patients living in rural areas.

This node is no longer active in the CTN.

DELAWARE VALLEY NODE PROTOCOL INVOLVEMENT
CTN-0002	Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification
CTN-0004	MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
CTN-0006	Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
CTN-0007	Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
CTN-0008	Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation
CTN-0010	Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescent/Young Adults
CTN-0012	Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
CTN-0018	Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
CTN-0019	Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
CTN-0027	Starting Treatment with Agonist Replacement Therapies (START)
CTN-0027-A-1	START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies
CTN-0027-A-2	Retention of Suboxone Patients in START: Perspectives of Providers and Patients
CTN-0028	Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents (with Substance Use Disorder)
CTN-0037	Stimulant Reduction Intervention Using Dosed Exercise (STRIDE)
CTN-0037-A-1	Site Influences on Treatment Effects - Exercise as a Treatment for Substance Use Disorders
CTN-0049	Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users (Project HOPE)
CTN-0050	Long Term Follow-Up of START Patients
CTN-0052	A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC)
CTN-0064	Linkage to Hepatitis C Virus (HCV) Care among HIV/HCV Co-infected Substance Users



RRTC Site \| www	RRTC Site \| www


www \| search	www \| search


www \| search	www \| search


www \| search	www \| search


www \| search	www \| search


www \| search	www \| search

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 5/2015 -- http://ctndisseminationlibrary.org/nodes/dvnode.htm
info@ctndisseminationlibrary.org